Hitchwood Capital Management LP Dexcom Inc Transaction History

Hitchwood Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $1.22 Million - $1.69 Million	-13,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $4.16 Million - $5.21 Million	-32,000 Reduced 71.11%	13,000 $6.98 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $4.8 Million - $6.44 Million	45,000 New	45,000 $24.6 Million
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $6.07 Million - $8.41 Million	-225,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $5.25 Million - $8.26 Million	225,000 New	225,000 $32.2 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Hitchwood Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hitchwood Capital Management LP with notifications on news.